Seattle, WANCT05930483Now EnrollingIRB Ready

Anatomic Stage I Breast Cancer AJCC v8 Clinical Trial in Seattle, WA

Access cutting-edge anatomic stage i breast cancer ajcc v8 treatment through this clinical trial at a research site in Seattle. Study-provided care at no cost to qualified participants.

Sponsored by Fred Hutchinson Cancer Center

Quick Self-Assessment

See if you qualify for this Seattle location

Preparing your pre-screening questions…

Expert Care in Seattle

Access anatomic stage i breast cancer ajcc v8 specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related anatomic stage i breast cancer ajcc v8 treatment provided free

Apply for This Seattle Location

Check if you qualify for this anatomic stage i breast cancer ajcc v8 clinical trial in Seattle, WA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Seattle

    Convenient for WA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Seattle site if eligible
  4. 4Begin participation

About This Anatomic Stage I Breast Cancer AJCC v8 Study in Seattle

This clinical trial evaluates remotely delivered, community-aligned weight loss interventions in Latina breast cancer survivors. Breast cancer is the second leading cause of cancer death among women in the US. There are population differences in breast cancer mortality, based on specific risk factors, including obesity. Cancer is the leading cause of death among Latinos, and among Latinas, breast cancer is the leading cause of cancer death. An estimated 80% of Latinas in the United States have overweight/obesity, which is associated with poorer breast cancer outcomes. However, few, if any, effective interventions exist to promote and maintain weight loss in Latina breast cancer survivors. The development of an adaptive program that provides survivors with the support they need, as opposed to what is typically available, to improve breast cancer survivorship.

Sponsor: Fred Hutchinson Cancer Center

Who Can Participate

Inclusion Criteria

Biologically female
Age \>= 18 years
Self-identifies Hispanic/Latina
Able to read and write in Spanish and/or English
Previous diagnosis of stage I-III BC within the past 5 years
No evidence of current, recurrent, or metastatic disease
60 days post treatment, including chemotherapy, radiation therapy, and cancer-related surgery (NOTE: current allowed therapies include endocrine therapy, CDK4/6 inhibitors (e.g. palbociclib,ribociclib, abemaciclib), HER2-directed therapies (e.g., trastuzumab, neratinib), and monoclonal antibodies (e.g., pertuzumab, pembrolizumab); surgery for breast reconstruction is allowed during the trial)
Body mass index (BMI) \>= 27 kg/m\^2 initially assessed via self-reported height and weight and confirmed prior to randomization via a tape measure and Bluetooth-enabled scale
Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1
Willingness to participate in all study activities
Access to phone for study contacts
Access to internet to participate in the online program and to be able to sync study devices
Successful completion of at-home baseline assessments prior to randomization

Exclusion Criteria

Body mass index (BMI) \< 27 kg/m\^2 at time of baseline data collection
Diabetic with current use of insulin or sulfonylurea medications (note: current use of metformin is allowed)
Use of glucagon-like peptide-1 (GLP1) receptor agonist medications reported at baseline
Current use of cytotoxic chemotherapy medications (e.g., capecitabine) or drug-antibody conjugates (e.g., trastuzumab emtansine \[T-DM1\], trastuzumab deruxtecan \[T-DXd\])
Major comorbidities or physical limitations that would preclude from healthy weight loss, reducing energy intake or engaging in PA
Pregnant, breastfeeding, or planning to become pregnant during the study period
Use of exogenous hormones for gender affirmation
For stool sample collection only: Self-reported use of oral or intravenous antibiotics, antifungals, or anti-parasitics during the past 6 months
For stool sample collection only: Presence of self-reported ileostomy or colostomy
For stool sample collection only: Presence of self-reported inflammatory bowel diseases (e.g., Crohn's disease, ulcerative colitis)
Anticipated major surgical procedure (e.g., hysterectomy) within 3 months after study registration. Breast reconstruction is allowed during study participation.
Concurrent enrollment in another weight loss or physical activity trial

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Seattle?

Yes, this clinical trial (NCT05930483) has an active research site in Seattle, WA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Anatomic Stage I Breast Cancer AJCC v8 Treatment Options in Seattle, WA

If you're searching for anatomic stage i breast cancer ajcc v8 treatment options in Seattle, WA, this clinical trial (NCT05930483) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Seattle research site is actively enrolling participants for this clinical trial. You'll receive care from experienced anatomic stage i breast cancer ajcc v8 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all anatomic stage i breast cancer ajcc v8 clinical trials near you to find additional studies recruiting in your area.

More Breast Cancer Trials in Seattle, WA

See all breast cancer clinical trials recruiting in Seattle — not just this study.

Browse Breast Cancer Trials in Seattle →

Browse More Trials by Condition

Breast Cancer TrialsHeart Attack TrialsAnkylosing Spondylitis TrialsInterstitial Cystitis TrialsMyocardial Infarction TrialsAll Conditions →

Ready to Join in Seattle?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Seattle, WA